Breaking: Vertex makes $10B deal for commercial endocrinology biotech Crinetics - Endpoints News

Breaking: Vertex makes $10B deal for commercial endocrinology biotech Crinetics - Endpoints News
Business

Listen to this article

0%

Ver­tex Phar­ma­ceu­ti­cals is mak­ing the largest ac­qui­si­tion in its his­to­ry, beef­ing up its com­mer­cial port­fo­lio with a $10 bil­lion takeover of Cri­net­ics Phar­ma­ceu­ti­cals. The Mon… [+3 chars]

Leave A Comment

Comments are moderated and may take time to appear.

Comments

No comments yet. Be the first to comment!

Stay Connected